melanotan 2 and autism ii study Melanotan-II did not significantly alter social behaviors in normal Reducing social deficits in autism: – Melanotan II (“Tan Jabs”): Why

doi: 10.1016/j.cell.2019.08.012 212 BeigiYZLanjanianHFayaziRSalimiMHoseyniBHMNoroozizadehMHet al

Choose quality, choose SOLGAR.

& Morrissey, J

Environment International 34(1): 139153

10.1111/j.1601-0825.2010.01671.x Oral Dis

Thirdly , theres also a patent application (IN202047010224) (pdf) pending by Novo Nordisk, filed in 2020 with priority date of 24/08/2017, for a specific formulation of semaglutide (the active ingredient in its commercial blockbuster drug, Ozempic) described as Semaglutide liquid formulations (no more than 0.01% (w/w) phenol. Adding to the complexity is a recent revocation petition filed by DRL in May 2025 (as reported by the media here)